New updates have been reported about Enzo Health.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Enzo Health has secured a $20 million Series A round led by N47, lifting total funding to $26 million and positioning the company to accelerate deployment of its AI-driven workflow platform across home health and broader post-acute care. The 2024-founded company reports more than 40x revenue growth in twelve months and adoption by organizations serving over 500,000 patients annually, signaling rapid market traction amid surging in-home care demand as over 10,000 Americans turn 65 each day.
The platform integrates front office, clinical operations, and back office processes from referral through reimbursement, using tools like Enzo Intake for rapid referral digitization and eligibility checks, Enzo Scribe for real-time OASIS validation and documentation at the point of care, and Enzo QA for continuous chart review to protect reimbursement and regulatory compliance. With the new capital, Enzo Health plans to extend this AI-native infrastructure into skilled nursing and hospice, targeting a market strained by Medicare cuts, tighter regulations, workforce shortages, and clinician turnover approaching 80 percent in the first 100 days, with the aim of improving margins for providers, reducing administrative burden, and enabling sustainable scaling of post-acute services.